RE:THE SCIENCEPalladium.very interesting point . Trillium has not wasted any money on Ir and pr . Look their management works . They have constant news flow and updates on their clinical trial. Almost a few a month . No bullshit . No flakey guys promising you the world . CEO has respect ... their US investors took them to the top. Last December Trilium was almost delisted from Nasaq. We need definitive results clinical and pharma collaboration. The market sp is telling us something.